AEON Biopharma, Inc. (AEON) stock
AEONNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.11−0.03 (-19.40%)
Close on Nov 17, 2026Market cap $5.66MP/E –Yield –
AEON Biopharma pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
AEON Biopharma's pe ratio was 0.2× on Jan 30, 2026.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jan 30, 2026 | 0.2× | +0.0 |
| 2025 | Dec 31, 2025 | 0.2× | – |
See a number that looks wrong?